Chief Executive Officer, Household Capital Pty Ltd
| Role | Organisation | Sources |
|---|---|---|
| Director (former) | Peplin Inc | GBS Ventures (3 Sep 2009), GBS Ventures (18 Aug 2008) |
| Chief Executive Officer | Household Capital Pty Ltd | Australian FinTech |
Stories naming Dr Joshua Funder. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Home equity retirement funder Household Capital has completed a Series C raise, bringing Genworth in alongside Legal & General as strategic investors, while a Genworth executive joins its board.
Also Techboard
Opal Therapeutics partners with Massachusetts General Hospital on an HIV immunotherapy collaboration as human trials begin in London; the biotech counts Alloy Ventures, Alta Partners and GBS Ventures among its backers.
Leo Pharma has agreed a US$287.5m cash takeover of Peplin, the ASX-listed skin-disease drug developer in GBS Ventures' portfolio; GBS recalls leading its late-2008 round alongside two American venture backers.
ASX-listed biotech Peplin arranged a private placement of roughly US$24 million to advance its keratosis drug into Phase III testing, led by GBS Venture Partners with several existing shareholders also taking part.